Journal of Law, Medicine & Ethics 38 (3):520-549 (2010)
“Access to medicines” is a broad concept. After a review of three authoritative frameworks that help to identify its constitutive components, this essay summarizes the actual situation on the ground in low- and middle-income countries on the basis of recent empirical work. An analysis of survey data from 36 countries concluded that developing countries should promote generic medicines as a key policy option for improving access to medicines. Taking an international perspective to that recommendation, this essay reviews the World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and, particularly, how this agreement has been applied in practice. As shown by the experience of Thailand, Brazil, and the Philippines, in order to deal effectively with international pressures for an excessive application of the TRIPS Agreement, some sort of conversion experience appears to be required, which then leads to a switch from a private enterprise, supply-driven approach to a public health vision that insists on universal and affordable access. But moral conviction is not sufficient. In order to muster and sustain the political will to face down international forces, civil society and government offices must be able and ready to show the costs and other adverse consequences of the TRIPS-based model for medicines. This calculation needs to reach beyond the health sector and calls for new alliances, nationally as well as internationally
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
References found in this work BETA
[Book Review] Sovereign Virtue, the Theory and Practice of Equality. [REVIEW]Ronald Dworkin - 2002 - Ethics 112 (2):367-371.
Citations of this work BETA
Global Health Governance: Commission on Social Determinants of Health and the Imperative for Change.Ruth Bell, Sebastian Taylor & Michael Marmot - 2010 - Journal of Law, Medicine & Ethics 38 (3):470-485.
Patent Funded Access to Medicines.Tom Andreassen - 2015 - Developing World Bioethics 15 (3):152-161.
Similar books and articles
GlaxoSmithKline and Access to Essential Medicines (B).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):123-132.
Improving Access to Essential Medicines: How Health Concerns Can Be Prioritised in the Global Governance System.Devi Sridhar - 2008 - Public Health Ethics 1 (2):83-88.
Poverty, Disease, and Medicines in Low- and Middle-Income Countries.Klaus M. Leisinger - 2012 - Business and Professional Ethics Journal 31 (1):135-185.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (1):3 - 23.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability Under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine & Ethics 40 (2):234-250.
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine & Ethics 40 (2):220-233.
Why Are Generic Drugs Being Held Up in Transit? Intellectual Property Rights, International Trade, and the Right to Health in Brazil and Beyond.Mônica Steffen Guise Rosina & Lea Shaver - 2012 - Journal of Law, Medicine & Ethics 40 (2):197-205.
Global Health Impact: A Basis for Labeling and Licensing Campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies.Meri Koivusalo - 2010 - Ethics and International Affairs 24 (4):395-414.
GlaxoSmithKline and Developing Country Access to Essential Medicines (A).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):97-121.
Race Against Time: The Export of Essential Medicines to Rwanda.Matthew Rimmer - 2008 - Public Health Ethics 1 (2):89-103.
Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions.Michael Ravvin - 2008 - Public Health Ethics 1 (2):110-123.
Pharmaceutical Companies and Access to Medicines – Social Integration and Ethical CSR Resolution of a Global Public Choice Problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
Added to index2010-09-30
Total downloads20 ( #242,627 of 2,153,472 )
Recent downloads (6 months)1 ( #399,080 of 2,153,472 )
How can I increase my downloads?